Location: New York, NY
CIK: 0001263508 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 15, 2026
Total Value: $17.42B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INCY | Incyte Corporation | 30,744,412 | $2.894B | 16.6% | $72.80 | +41.7% | COM | 45337C102 |
| ONC | BeOne Medicines Ltd. | 8,799,053 | $2.613B | 15.0% | $136.93 | — | SPONSORED ADS | 07725L102 |
| INSM | Insmed Incorporated | 7,421,111 | $1.214B | 7.0% | $68.84 | +131.0% | COM PAR $.01 | 457669307 |
| MDGL | Madrigal Pharmaceuticals, Inc. | 2,141,701 | $1.121B | 6.4% | $139.37 | +253.4% | COM | 558868105 |
| ACAD | ACADIA Pharmaceuticals Inc. | 42,896,690 | $955M | 5.5% | $18.93 | +33.2% | COM | 004225108 |
| RVMD | Revolution Medicines, Inc. | 9,555,357 | $929M | 5.3% | $30.13 | +241.9% | COM | 76155X100 |
| CELC | Celcuity Inc. | 7,915,792 | $904M | 5.2% | $21.19 | +407.1% | COM | 15102K100 |
| KOD | Kodiak Sciences Inc. | 19,919,186 | $759M | 4.4% | $29.02 | -12.4% | COM | 50015M109 |
| KYMR | Kymera Therapeutics, Inc. | 8,657,242 | $721M | 4.1% | $37.74 | +105.6% | COM | 501575104 |
| SMMT | Summit Therapeutics Inc. | 36,391,063 | $690M | 4.0% | $11.11 | +45.8% | COM | 86627T108 |
| PRAX | Praxis Precision Medicines, Inc. | 1,753,198 | $565M | 3.2% | $175.27 | +77.9% | COM | 74006W207 |
| RYTM | Rhythm Pharmaceuticals, Inc. | 5,604,483 | $487M | 2.8% | $23.49 | +337.9% | COM | 76243J105 |
| ALKS | Alkermes plc | 10,012,267 | $354M | 2.0% | $27.44 | +17.9% | SHS | G01767105 |
| GRAL | GRAIL, Inc. | 4,028,614 | $208M | 1.2% | $61.86 | +52.5% | COM | 384747101 |
| EWTX | Edgewise Therapeutics, Inc. | 6,575,940 | $207M | 1.2% | $14.29 | +97.1% | COM | 28036F105 |
| IONS | Ionis Pharmaceuticals, Inc. | 2,047,727 | $154M | 0.9% | $68.78 | +18.9% | COM | 462222100 |
| KNSA | Kiniksa Pharmaceuticals International, plc | 2,826,246 | $136M | 0.8% | $18.73 | +130.4% | ORD SHS CL A | G52694109 |
| IMVT | Immunovant, Inc. | 5,457,881 | $136M | 0.8% | $22.96 | +14.4% | COM | 45258J102 |
| ROIV | Roivant Sciences Ltd. | 4,867,723 | $135M | 0.8% | $12.94 | +86.8% | SHS | G76279101 |
| IDYA | IDEAYA Biosciences, Inc. | 3,946,515 | $131M | 0.8% | $21.75 | +55.7% | COM | 45166A102 |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 1,992,783 | $125M | 0.7% | $24.96 | +163.4% | COM | 04280A100 |
| STOK | Stoke Therapeutics, Inc. | 3,336,697 | $109M | 0.6% | $9.30 | +242.1% | COM | 86150R107 |
| IMTX | Immatics N.V. | 10,916,693 | $107M | 0.6% | $8.55 | +14.8% | SHS | N44445109 |
| ABCL | AbCellera Biologics Inc. | 30,275,938 | $106M | 0.6% | $19.44 | -81.2% | COM | 00288U106 |
| ABVX | Abivax S.A. | 875,796 | $97.52M | 0.6% | $84.90 | — | SPONSORED ADS | 00370M103 |
| CRNX | Crinetics Pharmaceuticals, Inc. | 2,351,465 | $85.41M | 0.5% | $44.30 | +11.1% | COM | 22663K107 |
| REPL | Replimune Group, Inc. | 11,045,336 | $84.5M | 0.5% | $14.45 | -46.0% | COM | 76029N106 |
| — | Celcuity Inc. | 30,750,000 | $74.87M | 0.4% | $1.33 | — | Note 2.75% 8/1/2031 | 15102KAA8 |
| NRIX | Nurix Therapeutics, Inc. | 4,658,556 | $72.21M | 0.4% | $20.95 | -17.2% | COM | 67080M103 |
| DNLI | Denali Therapeutics Inc. | 3,731,695 | $71.65M | 0.4% | $23.78 | -17.5% | COM | 24823R105 |
| DNTH | Dianthus Therapeutics, Inc. | 852,164 | $71.51M | 0.4% | $20.87 | +128.0% | COM | 252828108 |
| GLUE | Monte Rosa Therapeutics, Inc. | 4,345,736 | $71.49M | 0.4% | $6.49 | +218.2% | COM | 61225M102 |
| GPCR | Structure Therapeutics Inc. | 1,432,529 | $69.05M | 0.4% | $22.23 | — | SPONSORED ADS | 86366E106 |
| TRDA | Entrada Therapeutics, Inc. | 5,072,730 | $64.02M | 0.4% | $16.68 | — | COM | 29384C108 |
| BCYC | Bicycle Therapeutics plc | 10,885,357 | $50.51M | 0.3% | $20.78 | — | SPONSORED ADS | 088786108 |
| SYRE | Spyre Therapeutics, Inc. | 1,000,000 | $50.44M | 0.3% | $15.36 | +124.8% | COM | 00773J202 |
| RAPP | Rapport Therapeutics, Inc. | 1,547,090 | $48.41M | 0.3% | $15.27 | +82.3% | COM | 75383L102 |
| ALMS | Alumis Inc. | 2,012,500 | $44.34M | 0.3% | $15.77 | +54.3% | COM | 022307102 |
| MIRM | Mirum Pharmaceuticals, Inc. | 445,975 | $41.2M | 0.2% | $96.57 | 0.0% | COM | 604749101 |
| VRDN | Viridian Therapeutics, Inc. | 1,971,678 | $38.57M | 0.2% | $15.17 | +103.3% | COM | 92790C104 |
| ELVN | Enliven Therapeutics, Inc. | 905,191 | $35.48M | 0.2% | $23.32 | +9.8% | COM | 29337E102 |
| PRLD | Prelude Therapeutics Inc. | 10,123,824 | $34.62M | 0.2% | $28.24 | -91.8% | COM | 74065P101 |
| DBVT | DBV Technologies S.A. | 1,461,425 | $30.53M | 0.2% | $3.09 | — | SPONSORED ADS | 23306J309 |
| DSGN | Design Therapeutics, Inc. | 2,585,978 | $27.51M | 0.2% | $10.92 | -8.6% | COM | 25056L103 |
| CNTA | Centessa Pharmaceuticals plc | 670,751 | $26.64M | 0.2% | $25.01 | — | SPONSORED ADS | 152309100 |
| CTMX | CytomX Therapeutics, Inc. | 4,975,826 | $23.39M | 0.1% | $2.24 | +133.6% | COM | 23284F105 |
| JBIO | Jade Biosciences, Inc. | 1,641,137 | $23.06M | 0.1% | $11.73 | +26.0% | COM | 008064206 |
| IRON | Disc Medicine, Inc. | 349,657 | $22.36M | 0.1% | $50.34 | +47.1% | COM | 254604101 |
| IMCR | Immunocore Holdings plc | 734,397 | $22.14M | 0.1% | $38.09 | — | ADS | 45258D105 |
| XENE | Xenon Pharmaceuticals Inc. | 370,208 | $21.53M | 0.1% | $19.37 | +116.7% | COM | 98420N105 |
| CLDX | Celldex Therapeutics, Inc. | 665,370 | $21.11M | 0.1% | $23.17 | +9.7% | COM | 15117B202 |
| NGNE | Neurogene Inc. | 991,691 | $19.99M | 0.1% | $19.35 | -6.2% | COM | 64135M105 |
| EVMN | Evommune, Inc. | 847,390 | $19.48M | 0.1% | $21.99 | 0.0% | COM SHS | 30054Y107 |
| TECX | Tectonic Therapeutic, Inc. | 607,788 | $18.79M | 0.1% | $20.13 | +4.8% | COM | 878972108 |
| CTNM | Contineum Therapeutics, Inc. | 1,420,838 | $18.56M | 0.1% | $11.67 | +14.5% | CL A | 21217B100 |
| ARGX | argenx SE | 25,174 | $18.38M | 0.1% | $79.01 | — | SPONSORED ADR | 04016X101 |
| CERS | Cerus Corporation | 10,008,345 | $18.22M | 0.1% | $4.19 | -44.1% | COM | 157085101 |
| TSHA | Taysha Gene Therapies, Inc. | 4,004,756 | $17.9M | 0.1% | $1.91 | +148.6% | COM SHS | 877619106 |
| AKTS | Aktis Oncology, Inc. | 996,351 | $17.82M | 0.1% | $17.89 | — | COM | 01021M104 |
| GENB | Generate Biomedicines, Inc. | 1,423,602 | $17.8M | 0.1% | $12.50 | — | COM SHS | 370920100 |
| SION | Sionna Therapeutics, Inc. | 400,000 | $16.04M | 0.1% | $16.34 | +140.2% | COM | 829401108 |
| DYN | Dyne Therapeutics, Inc. | 813,449 | $14.75M | 0.1% | $18.94 | -9.6% | COM | 26818M108 |
| XNCR | Xencor, Inc. | 1,102,106 | $13.29M | 0.1% | $16.65 | -24.0% | COM | 98401F105 |
| CMPS | COMPASS Pathways plc | 2,344,720 | $12.97M | 0.1% | $5.53 | — | SPONSORED ADS | 20451W101 |
| RLAY | Relay Therapeutics, Inc. | 1,160,117 | $11.54M | 0.1% | $13.78 | -39.8% | COM | 75943R102 |
| SERA | Sera Prognostics, Inc. | 5,498,170 | $11.16M | 0.1% | $3.09 | -4.6% | CLASS A COM | 81749D107 |
| BNTX | BioNTech SE | 119,743 | $10.64M | 0.1% | $107.38 | — | SPONSORED ADS | 09075V102 |
| PHVS | Pharvaris N.V. | 375,000 | $10.59M | 0.1% | $22.18 | +20.6% | COM | N69605108 |
| RCUS | Arcus Biosciences, Inc. | 415,621 | $8.977M | 0.1% | $20.71 | +2.7% | COM | 03969F109 |
| MPLT | MapLight Therapeutics, Inc. | 364,705 | $7.414M | 0.0% | $16.75 | +5.2% | COM | 56565P103 |
| ABSI | Absci Corporation | 2,134,803 | $6.404M | 0.0% | $3.64 | -17.6% | COM | 00091E109 |
| WVE | Wave Life Sciences Ltd. | 822,638 | $5.964M | 0.0% | $10.50 | +31.0% | SHS | Y95308105 |
| VTVT | vTv Therapeutics, Inc. | 148,314 | $5.882M | 0.0% | $14.29 | +152.7% | CL A | 918385204 |
| EIKN | Eikon Therapeutics, Inc. | 555,555 | $5.878M | 0.0% | $10.58 | — | COM | 282564103 |
| TARA | Protara Therapeutics, Inc. | 971,614 | $5.062M | 0.0% | $9.86 | -37.3% | COM STK | 74365U107 |
| SGMT | Sagimet Biosciences Inc. | 952,996 | $4.979M | 0.0% | $9.53 | -39.1% | COM SER A | 786700104 |
| LBRX | LB Pharmaceuticals Inc. | 200,000 | $4.932M | 0.0% | $15.87 | +41.1% | COM SHS | 50180M108 |
| VSTM | Verastem, Inc. | 584,757 | $3.099M | 0.0% | $6.48 | 0.0% | COM | 92337C203 |
| TCRX | TScan Therapeutics, Inc. | 2,784,792 | $2.813M | 0.0% | $6.08 | -82.4% | COM | 89854M101 |
| SKYE | Skye Bioscience, Inc. | 1,575,243 | $968K | 0.0% | $7.20 | -87.6% | COM | 83086J200 |
| SANA | Sana Biotechnology, Inc. | 310,483 | $894K | 0.0% | $4.55 | -4.8% | COM | 799566104 |
| ALGS | Aligos Therapeutics, Inc. | 83,055 | $617K | 0.0% | $12.44 | -36.4% | COM | 01626L204 |
| TYRA | Tyra Biosciences, Inc. | 10,607 | $406K | 0.0% | $12.95 | +133.7% | COM | 90240B106 |
| SRZNW | Surrozen, Inc. | 833,333 | $13,333 | 0.0% | $1.14 | — | W EXP 8/11/2026 | 86889P117 |